Intra Cellular Therapies Inc
ITCI
|
|
|
|
Trading Volume | 9,330 |
|
79.03 - 46.37 |
Market Cap Full | $ 6.9B |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 0.3% | -3.5% | 2.3% | 17% |
Q2 | - | 3.9% | 16.9% | -6.8% |
Q3 | - | -8.6% | -17.7% | -18.5% |
Q4 | - | -6.6% | 36.5% | 13.7% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
0.3 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
-6 | 3.2 | -0.6 | 4.6 | -6.9 | 5.3 | 11.1 | -8.6 | - | - | - | -2.4 |
2023 | |||||||||||
-9.5 | 2.3 | 10.4 | 14.8 | -4.5 | 6.6 | -2.3 | -10.2 | -6.2 | -4.5 | 23.3 | 16.7 |
2022 | |||||||||||
-10.4 | 18.3 | 10.4 | -17.3 | 13.4 | -0.6 | -5.2 | -7.1 | -7.4 | -1.9 | 18.7 | -2.4 |
2021 | |||||||||||
1.1 | 5.2 | 0.4 | 1.5 | 14.5 | 3.6 | -15.9 | -3.3 | 9.7 | 18.3 | -7.1 | 30.8 |
2020 | |||||||||||
-36 | -4.3 | -27.2 | 15 | 18.2 | 22.9 | -22.8 | -8.1 | 40.8 | -7.7 | -0.2 | 34.5 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | -0.5 | -0.8 | -0.7 | -0.7 |
Q2 | -0.5 | -0.9 | -0.9 | -1 |
Q3 | -0.3 | -0.6 | -1 | -0.8 |
Q4 | 0 | -0.5 | -1.1 | -0.8 |
A | -1.16 | -2.7 | -3.5 | -3.2 |